Senda Biosciences
Senda Biosciences | Pioneering Intersystems Biology.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD760m—1.1b (Dealroom.co estimates Aug 2022.)
Cambridge Massachusetts (HQ)
Financials
Estimates*
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 1.3m | 3.1m | 7.4m | 14.1m | 23.6m |
% growth | - | 140 % | 140 % | 90 % | 67 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$88.0m | Series A | ||
$55.0m | Series B | ||
* | $123m | Series C | |
* | N/A | Merger | |
Total Funding | AUD411m |